Based in Boston, Genosco is a clinical stage biotech specializing in
the discovery and development of novel kinase inhibitors for
patients with unmet medical needs
Based in Boston, Genosco is a clinical stage
biotech specializing in the discovery and development
of novel kinase inhibitors for patients with unmet
medical needs
-
01.Experienced
TeamDedicated team of experts in
kinase targeted therapies -
02.Proprietary
Discovery
PlatformGENO-KTM/GENO-DTM platform enables us to identify rare sequences and rapidly generate highly selective compounds
-
03.Strong and
Diverse
PipelineMultiple independent and
partnered pipelines -
04.Proven Track
RecordBacked by proven R&D through global out-licensing partnership
-
01.Experienced
TeamDedicated team of experts in
kinase targeted therapies -
02.Proprietary
Discovery
PlatformGENO-KTM/GENO-DTM platform enables us to identify rare sequences and rapidly generate highly selective compounds
-
03.Strong and
Diverse
PipelineMultiple independent and
partnered pipelines -
04.Proven Track
RecordBacked by proven R&D through global out-licensing partnership
-
Protein
Database -
Ligand
Library -
Rare Sequence
Targeting
-
Protein Degrader
Library -
Degrader Screening
Technology -
Degrader Design
Technology
- Idiopathic Pulmonary Fibrosis (IPF)
- Cerebral Cavernous Malformation (CCM)
To achieve this, it is important to focus on strengthening the discovery platform based on cutting-edge science,
and to create an open and positive working environment where employees can unleash their full creativity.